The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials

Bayer's first academic medical center alliance for clinical trial collaboration is designed to accelerate medical discovery and expand patient access to investigational therapies

AURORA, Colo. and WHIPPANY, N.J., July 7, 2026 /PRNewswire/ -- Bayer, a global life sciences company, has announced a new strategic alliance focused on clinical trials collaboration with the University of Colorado Anschutz, UCHealth and Children's Hospital Colorado, establishing Bayer's first alliance of its kind with an academic medical center. The initiative reflects a shared commitment to accelerating clinical research through stronger collaboration between industry and academic medicine.

Bayer executives pose for a photo with CU Anschutz leaders.

Bayer executives pose for photo with leaders from CU Anschutz, UCHealth, and Children's Hospital Colorado.

Logo for Bayer